<qa>  What is the goal of a phase II study?This is a randomized phase II study, aimed at evaluating the efficacy through progression free survival at 6 months and safety of 5 different treatments involving atezolizumab, bevacizumab andor acetylsalicylic acid in advanced recurrent platinum-resistant ovarian cancer patients in order to select the optimal treatments for further development in Phase III. 